Profiel
Nikhil Mehta worked as Vice President-Global Regulatory Affairs at Merck & Co., Inc. from 2010 to 2015.
He then worked as Chief Regulatory Strategist & Executive VP at Tang Capital Management LLC.
In 2015, he joined Baxalta, Inc. as Global Head-Regulatory Affairs, where he worked until 2016.
From 2017 to 2019, he worked as Senior VP-Regulatory & Quality Assurance at AVEO Pharmaceuticals, Inc. Dr. Mehta holds a doctorate degree from Rutgers State University of New Jersey.
Eerdere bekende functies van Nikhil Mehta
| Bedrijven | Functie | Einde |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Algemeen Adviseur | 08-10-2019 |
| BAXALTA INC | Algemeen Adviseur | 01-06-2016 |
| MERCK & CO., INC. | Algemeen Adviseur | 01-01-2015 |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Algemeen Adviseur | - |
Opleiding van Nikhil Mehta
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
















